Business Description
Hindustan Bio Sciences Ltd
ISIN : INE597C01021
Compare
Compare
Traded in other countries / regions
532041.India IPO Date
1996-10-07Description
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin, and others. Geographically, the group sells its products within India and also exports it to other countries.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 2.78 | |||||
| Debt-to-EBITDA | 16.08 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.62 | |||||
| Beneish M-Score | -0.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.1 | |||||
| 3-Year Book Growth Rate | -14.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.34 | |||||
| 9-Day RSI | 52.8 | |||||
| 14-Day RSI | 52.18 | |||||
| 6-1 Month Momentum % | 18.34 | |||||
| 12-1 Month Momentum % | 11.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 84.78 | |||||
| Quick Ratio | 84.78 | |||||
| Cash Ratio | 20.38 | |||||
| Days Sales Outstanding | 101.61 | |||||
| Days Payable | 1.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.75 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.65 | |||||
| Operating Margin % | 11.91 | |||||
| Net Margin % | 12.82 | |||||
| FCF Margin % | -124.4 | |||||
| ROE % | 18.69 | |||||
| ROA % | 4.42 | |||||
| ROIC % | 4.21 | |||||
| ROC (Joel Greenblatt) % | 17.53 | |||||
| ROCE % | 4.84 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 74.89 | |||||
| PE Ratio without NRI | 74.89 | |||||
| PS Ratio | 9.58 | |||||
| PB Ratio | 13.14 | |||||
| Price-to-Tangible-Book | 13.06 | |||||
| EV-to-EBIT | 93.81 | |||||
| EV-to-EBITDA | 90.77 | |||||
| EV-to-Revenue | 11.58 | |||||
| EV-to-FCF | -9.35 | |||||
| Price-to-Median-PS-Value | 5.25 | |||||
| Price-to-Graham-Number | 6.61 | |||||
| Earnings Yield (Greenblatt) % | 1.06 | |||||
| FCF Yield % | -12.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hindustan Bio Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 11.326 | ||
| EPS (TTM) (₹) | 0.143 | ||
| Beta | -1.51 | ||
| Volatility % | 55.3 | ||
| 14-Day RSI | 52.18 | ||
| 14-Day ATR (₹) | 0.401694 | ||
| 20-Day SMA (₹) | 10.5505 | ||
| 12-1 Month Momentum % | 11.11 | ||
| 52-Week Range (₹) | 6.86 - 13.47 | ||
| Shares Outstanding (Mil) | 10.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hindustan Bio Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hindustan Bio Sciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hindustan Bio Sciences Ltd Frequently Asked Questions
What is Hindustan Bio Sciences Ltd(BOM:532041)'s stock price today?
The current price of BOM:532041 is ₹10.71. The 52 week high of BOM:532041 is ₹13.47 and 52 week low is ₹6.86.
When is next earnings date of Hindustan Bio Sciences Ltd(BOM:532041)?
The next earnings date of Hindustan Bio Sciences Ltd(BOM:532041) is .
Does Hindustan Bio Sciences Ltd(BOM:532041) pay dividends? If so, how much?
Hindustan Bio Sciences Ltd(BOM:532041) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers